Insider Selling: Trupanion (NASDAQ:TRUP) COO Sells 431 Shares of Company Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 431 shares of the company’s stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $29.12, for a total transaction of $12,550.72. Following the completion of the transaction, the chief operating officer owned 32,880 shares of the company’s stock, valued at approximately $957,465.60. This trade represents a 1.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Trupanion Trading Down 0.2%

Trupanion stock traded down $0.06 during trading on Friday, reaching $30.13. 330,648 shares of the company were exchanged, compared to its average volume of 434,998. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The stock’s 50 day simple moving average is $26.90 and its two-hundred day simple moving average is $26.72. The company has a market capitalization of $1.32 billion, a P/E ratio of 56.85, a PEG ratio of 1.77 and a beta of 1.44. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $46.98.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. The firm had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.22 EPS. On average, equities research analysts expect that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on TRUP. Cantor Fitzgerald cut their price target on shares of Trupanion from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Wednesday, October 7th. Stifel Nicolaus lifted their target price on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Finally, Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $45.00 to $32.00 in a research report on Wednesday, August 26th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $38.40.

Institutional Trading of Trupanion

A number of hedge funds have recently modified their holdings of TRUP. BlackRock Inc. bought a new stake in Trupanion in the 2nd quarter valued at $134,774,000. Dimensional Fund Advisors LP boosted its stake in shares of Trupanion by 15.7% in the first quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider’s stock valued at $17,981,000 after buying an additional 95,064 shares during the period. Bank of America Corp DE acquired a new stake in Trupanion during the second quarter worth about $14,262,000. Kopion Asset Management LLC lifted its stake in Trupanion by 30.9% during the second quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider’s stock worth $12,955,000 after purchasing an additional 123,308 shares during the last quarter. Finally, Renaissancere Holdings Ltd. bought a new position in Trupanion in the second quarter valued at about $6,514,510.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.